Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.66 USD | -1.27% | -6.80% | -17.52% |
May. 09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
May. 08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
Financials (USD)
Sales 2024 * | 25.69M | Sales 2025 * | 16.86M | Capitalization | 321M |
---|---|---|---|---|---|
Net income 2024 * | -116M | Net income 2025 * | -149M | EV / Sales 2024 * | 0.91 x |
Net cash position 2024 * | 297M | Net cash position 2025 * | 286M | EV / Sales 2025 * | 2.05 x |
P/E ratio 2024 * |
-2.9
x | P/E ratio 2025 * |
-2.45
x | Employees | 145 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.26% |
Latest transcript on C4 Therapeutics, Inc.
1 day | -1.27% | ||
1 week | -6.80% | ||
Current month | -6.80% | ||
1 month | -27.75% | ||
3 months | -57.64% | ||
6 months | +258.46% | ||
Current year | -17.52% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Hirsch
CEO | Chief Executive Officer | 53 | 20-09-13 |
Kendra Adams
DFI | Director of Finance/CFO | 47 | 20-11-19 |
Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Downey
CHM | Chairman | 76 | 15-11-30 |
Glenn Dubin
BRD | Director/Board Member | 67 | 21-03-11 |
Bihua Chen
PRN | Corporate Officer/Principal | 55 | 15-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 1,557 M€ | +8.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 4.66 | -1.27% | 902,268 |
24-06-06 | 4.72 | -4.65% | 1,068,793 |
24-06-05 | 4.95 | +1.02% | 1,093,569 |
24-06-04 | 4.9 | +1.24% | 1,487,383 |
24-06-03 | 4.84 | -3.20% | 1,366,559 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.52% | 321M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- CCCC Stock